Importance of Evaluating Cardiovascular Risk and Hepatic Fibrosis in Patients With Newly Diagnosed Nonalcoholic Fatty Liver Disease.
Moreno-Del Castillo MC, Sanchez-Rodriguez A, Hernandez-Buen Abad JJ, Aguirre-Valadez J, Ruiz I, Garcia-Buen Abad R, Oliva K, Piccolo J, De Icaza-Del Rio E, Mena-Ramirez JR, Mendizabal-Rodriguez ME, Atkinson-Ginsburg NM, Salazar-Segovia J, Ríos-Zertuche Caceres A, Garcia-Juarez I.
Moreno-Del Castillo MC, et al. Among authors: piccolo j.
Clin Gastroenterol Hepatol. 2019 Apr;17(5):997-999. doi: 10.1016/j.cgh.2018.07.039. Epub 2018 Aug 2.
Clin Gastroenterol Hepatol. 2019.
PMID: 30077785